SCHEDULE 13D

Company

RHYTHM PHARMACEUTICALS, INC.

Filed

October 20, 2017

Accession Number

0000947871-17-000819

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →